Description
About Precision NanoSystems
Precision NanoSystems Inc. (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.
Exceptional Versatility:
Example Application
Nucleic Acid Lipid Nanoparticles (LNP)
- Rare genetic diseases
- mRNA protein replacement
- mRNA vaccines
- Gene and cell therapy
Liposomes
- Vaccine adjuvants
- Antimicrobials
- Cancer chemotherapy
- Diabetes combination therapy
Polymer NPs
- Cancer chemotherapy
- Targeted protein delivery
- Controlled release/biodistribution
- Immuno-oncology
Emulsions
- Cancer chemotherapy
- Drug formulation
- Controlled release/biodistribution
Organic/ inorganic NPs
- Theranostics
- Imaging
Carrier Materials:
Nucleic Acid Lipid Nanoparticles (LNP)
- Rare genetic diseases
- mRNA protein replacement
- mRNA vaccines
- Gene and cell therapy
Liposomes
- Vaccine adjuvants
- Antimicrobials
- Cancer chemotherapy
- Diabetes combination therapy
Polymer NPs
- Cancer chemotherapy
- Targeted protein delivery
- Controlled release/biodistribution
- Immuno-oncology
Emulsions
- Cancer chemotherapy
- Drug formulation
- Controlled release/biodistribution
Organic/ inorganic NPs
- Theranostics
- Imaging
